Instantaneous Wave-Free Ratio for the Assessment of Intermediate Left Main Coronary Artery Stenosis: Correlations With Fractional Flow Reserve/Intravascular Ultrasound and Prognostic Implications: The iLITRO-EPIC07 Study.

Journal Information

Full Title: Circ Cardiovasc Interv

Abbreviation: Circ Cardiovasc Interv

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Vascular Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosures Dr Pérez de Prado has received personal fees from iVascular, Boston Scientific, Terumo, B. Braun‚ and Abbott Vascular. The other authors report no conflicts."

Evidence found in paper:

"Sources of Funding The study sponsor, Fundación EPIC, has received an institutional research grant from Phillips Volcano (the Netherlands) to cover the design and maintenance costs of the electronic CRD. Philips Volcano has had no influence on the study design or protocol in any respect. Philips Volcano is not involved in the conduct of the study, including inclusion, follow-up, data collection, analysis, interpretation of results, drafting, and final approval of the protocol, nor in that of this article. The authors are solely responsible for the design of the study, the writing and editing of the article, and its final content."

Evidence found in paper:

"The study was approved by the reference ethics committee and notified to the local ethics committee of all participant centers. The study was registered in Clinicaltrials.gov with registration number NCT03767621. Only devices with CE (Conformité Européenne) marking were used, and only for the indications already approved. The study observed the principles established by the Declaration of Helsinki. All patients gave their written informed consent prior to participation in the study. The data that support the findings of this study are available from the corresponding author upon reasonable request. Registration:: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03767621."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025